Involvement of 5-HT2A, 5-HT2Band 5-HT2Creceptors in mediating the ventrolateral orbital cortex-induced antiallodynia in a rat model of neuropathic pain

The present study examined the roles of 5-HT2A, 5-HT2Band 5-HT2Creceptor subtypes in mediating the ventrolateral orbital cortex (VLO)-induced antiallodynia in a rat model of neuropathic pain induced by spared nerve injury (SNI). Change of mechanical paw withdrawal threshold (PWT) was measured using von-Frey filaments. Microinjection of preferential or selective 5-HT2A/C, 5-HT2Band 5-HT2Creceptor agonists, (±)-1-(2,5-Dimethoxy-4-iodophenyl)-2-aminopropane hydrochloride (DOI), α-methyl-5-(2-thienylmethoxy)-1H-Indole-3-ethanamine hydrochloride (BW723C86) and 1-(3-Chlorophenyl)-piperazine hydrochloride (m-CPP) into the VLO significantly depressed allodynia induced by SNI, and the inhibitory effect of DOI was blocked or attenuated by selective 5-HT2A/Creceptor antagonists ketanserin (+)-tartrate salt (ketanserin) and 5-HT2Areceptor antagonist R-(+)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenylethyl)]-4-piperidinemethanol (M100907); the effects of BW723C86 and m-CPP were antagonized by 5-HT2Breceptor antagonists N-(1-Methyl-1H-5-indolyl)-N′-(3-methyl-5-isothiazolyl)urea (SB204741) and 5-HT2Creceptor antagonist RS102221 hydrochloride hydrate (RS-102221), respectively. These results suggest that 5-HT2A, 5-HT2B, 5-HT2Creceptor subtypes are involved in mediating the VLO-induced antiallodynia in the neuropathic pain state.